financetom
Business
financetom
/
Business
/
Valero Energy's Q1 Adjusted Earnings, Revenue Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Valero Energy's Q1 Adjusted Earnings, Revenue Decline
Apr 25, 2024 4:40 AM

07:26 AM EDT, 04/25/2024 (MT Newswires) -- Valero Energy ( VLO ) reported Q1 adjusted earnings Thursday of $3.82 per diluted share, down from $8.27 a year earlier.

Analysts polled by Capital IQ expected $3.22.

Revenue for the quarter ended March 31 was $31.76 billion, down from $36.44 billion a year earlier.

Analysts surveyed by Capital IQ expected $33.11 billion.

Shares of Valero Energy ( VLO ) were up less than 1% in recent Thursday premarket activity.

Price: 168.49, Change: +1.49, Percent Change: +0.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Caesars Entertainment Opens Caesars Virginia Resort, Casino
Caesars Entertainment Opens Caesars Virginia Resort, Casino
Dec 18, 2024
04:22 AM EST, 12/18/2024 (MT Newswires) -- Caesars Entertainment ( CZR ) said late Tuesday it has opened its Caesars Virginia resort and casino in the city of Danville. The 587,000-square-foot resort includes gambling space and a 320-room hotel, among other facilities. ...
UniCredit ups Commerzbank stake as BPM bid faces hurdles
UniCredit ups Commerzbank stake as BPM bid faces hurdles
Dec 18, 2024
* UniCredit ups Commerzbank stake via derivatives to 28% * Process ongoing to seek authorisation for stake of up to 29.9% * UniCredit also trying to buy Italian rival BPM * BPM's market price well above UniCredit bid's price (Adds comments from Commerzbank in paragraph 4, details in 8-10) MILAN, Dec 18 (Reuters) - UniCredit has raised its stake in...
Eli Lilly's Kisunla Approved for Early Alzheimer's Patients in China
Eli Lilly's Kisunla Approved for Early Alzheimer's Patients in China
Dec 18, 2024
04:17 AM EST, 12/18/2024 (MT Newswires) -- Eli Lilly ( LLY ) said late Tuesday that China's National Medical Products Administration has approved its therapy Kisunla for adults with early symptomatic Alzheimer's disease or with the mild dementia stage of Alzheimer's disease who have confirmed amyloid pathology. The application to the Chinese regulator was based on efficacy and safety data...
Azul Commences Exchange Offers for 2029, 2030 Senior Notes
Azul Commences Exchange Offers for 2029, 2030 Senior Notes
Dec 18, 2024
04:15 AM EST, 12/18/2024 (MT Newswires) -- Azul ( AZUL ) said late Tuesday its Azul Secured Finance subsidiary has commenced offers to exchange its outstanding 11.500% senior secured second out notes due 2029 and 10.875% senior secured second out notes due 2030. The company is looking to exchange the existing notes for newly issued notes that carry the same...
Copyright 2023-2026 - www.financetom.com All Rights Reserved